Regulatory query on nitrosamines during regulatory inspection – CAPA for nitrosamine findings
Identifying symptoms indicative of potential nitrosamine issues is crucial for timely interventions. Pharmaceutical professionals should be vigilant in monitoring both production floor observations and lab results. Common symptoms include:Click to…